GetPortalImpactFactorByIdResp(projectId=1, id=46d224053, cover=https://img.medsci.cn/202201020/1666301726867_4754896.gif, fullname=Cardiovascular Revascularization Medicine, abbr=CARDIOVASC REVASCULA, pyear=暂无数据, frequence=Monthly, articleNumbers=1465, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2022年中国人文章占该期刊总数量300.00% , issn=1553-8389, greenSci=https://www.greensci.net/search?kw=1553-8389, scijournal=https://www.scijournal.org/impact-factor-of-CARDIOVASC-REVASCULA.shtml, medsciHotlightString=null, medsciHotlightRealtime=0.999, medsciHotlight=0.717, medsciHotlight5year=0.154, citescore=2.0, hIndex=35, impactFactor=1.7, orgnization=Elsevier Inc., orgnizationUrl=null, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=Scopus; Embase; PubMed/Medline, bigclassCas=null, smallclassCas=, website=https://www.sciencedirect.com/journal/cardiovascular-revascularization-medicine, websiteHits=131, guideForAuthor=https://www.elsevier.com/journals/cardiovascular-revascularization-medicine/1553-8389/guide-for-authors, guideForAuthorHits=130, submitWebsite=https://www.editorialmanager.com/CRM/default.aspx, submitWebsiteHits=112, content=<p><strong style="color: #2e2e2e;"><em>Cardiovascular Revascularization Medicine (CRM)</em></strong><span style="color: #2e2e2e;"> is an international, English-language, multidisciplinary, peer-reviewed journal that publishes original laboratory and clinical investigations related to </span><strong style="color: #2e2e2e;">revascularization therapies</strong><span style="color: #2e2e2e;"> in </span><strong style="color: #2e2e2e;">cardiovascular medicine</strong><span style="color: #2e2e2e;">. CRM publishes 12 regular print issues and a supplemental issue each year.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">The journal is indexed on Index Medicus and MEDLINE®/PubMed®.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">The journal's location in Washington, DC, gives it an advantage in reporting on regulatory issues as they pertain to interventional cardiology and structural heart disease. The journal is read by cardiologists, interventional cardiologists, structural heart interventionalists, vascular physicians, healthcare regulators, industry, fellows in training, and innovators around the globe.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">CRM</strong><span style="color: #2e2e2e;"> is also the official journal of the Cardiovascular Research Technologies (CRT) meeting, a premier event that brings together about 3,000 interventional cardiologists annually to discuss cutting-edge research and innovations. Attendees are encouraged to submit papers based on abstracts, interesting cases, late-breaking trials, and innovations presented at the meeting that impact interventional cardiologists' practice. The journal structures its content to reflect topics based on each track of the CRT meeting: Complex Coronary, Valve and Structural, Endovascular, Imaging and Physiology, Atherosclerosis, Cardiogenic Shock, Technology and Innovation, Regulatory and Healthcare Policy, and Innovations.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">CRM </strong><span style="color: #2e2e2e;">publishes articles related to preclinical and clinical work, including pharmacological interventions, and restenosis management; and treatment, including experiments conducted in human subjects, laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, genetics and translational science, health services and outcomes research, invasive imaging, regulatory and health policy, technology and innovation, and vascular medicine.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">The journal's nearest competitors are JACC: Cardiovascular Interventions, Circulation: Cardiovascular Interventions, and EuroIntervention.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">CRM</strong><span style="color: #2e2e2e;"> will consider all articles describing clinical trials and translational research (i.e., those that unite the clinic with the laboratory). The journal publishes original articles, research letters, reviews, editorials, and special features. Original articles that address any aspect of cardiovascular revascularization or structural intervention are invited. Letters to the editor, trial design papers, and interesting images are encouraged. The journal's peer-review process is single-blind.</span></p>, totalCites=2492, brief=CARDIOVASC REVASCULA杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=46d224053'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=null, medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.308), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.922), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.973), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=0.999)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1553-8389[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Cardiovascular Revascularization Medicine[ta], article_number=379, article_number_cn=3, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)